SAMANTHA CARNEY: Open Payments
NPI 1164985099 · FRANKFORT, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,123 in 86 payments from 30 companies in 2025. Trend: 2023 $1,472 · 2024 $2,437 · 2025 $3,123
Food & beverage: $2,033Consulting: $621Education: $369Long term medical supply or device loan: $100
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $801 |
| AstraZeneca Pharmaceuticals LP | 15 | $385 |
| Novartis Pharmaceuticals Corporation | 9 | $263 |
| Daiichi Sankyo Inc. | 5 | $227 |
| Astellas Pharma US Inc | 5 | $210 |
| Janssen Biotech, Inc. | 4 | $166 |
| Genentech USA, Inc. | 5 | $110 |
| Ipsen Biopharmaceuticals, Inc | 2 | $110 |
| ARRAY BIOPHARMA INC | 4 | $93 |
| Geron Corporation | 3 | $93 |
Products named: SARCLISA, ENHERTU, KISQALI, Xtandi, DARZALEX, RYTELO, LORBRENA, LYNPARZA.
Industry payments across IN — which companies pay providers there.
